Human Rabies Vaccine For Cat Related Injuries Prevention

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. is a professional China manufacturer providing reliable rabies prevention solutions. Human Rabies Vaccine For Cat Related Injuries Prevention is developed to support post-exposure protection needs caused by cat scratches and bites. With products supplied to more than 2000 CDC institutions and medical institutions across China, AIM Honor provides trusted vaccine solutions for global rabies prevention programs.

For individuals exposed to cat scratches, bites, or saliva contact from cats, AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides Human Rabies Vaccine For Cat Related Injuries Prevention as a professional rabies protection solution from a qualified China vaccine supplier. Based on the company’s rabies vaccine development capability, the product portfolio includes conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine, designed to meet different medical prevention requirements after cat-related injuries.

Cat-related injuries may happen during daily interaction with domestic cats, stray cats, or free-roaming cats. Because rabies remains one of the most serious viral infectious diseases, timely wound management and standardized vaccination are essential after potential exposure. AIM Honor focuses on providing safe and standardized vaccine products to support healthcare institutions and individuals in rabies prevention and control.

Product Overview

Human Rabies Vaccine For Cat Related Injuries Prevention is designed for post-exposure rabies prevention after cat-related injuries. The vaccine helps stimulate the immune system to produce protective antibodies against rabies virus after vaccination according to the recommended immunization schedule.

AIM Honor’s rabies vaccine products use Vero cell culture technology. The conventional vaccine uses the indigenous aG strain, while the serum-free vaccine uses the PV-2061 strain. Both products focus on high immunogenicity, safety, and standardized manufacturing processes.

The vaccine solutions are suitable for medical institutions, CDC organizations, and professional healthcare providers that require reliable rabies prevention products for people exposed to cat scratches and bites.

Why Cat Injuries Need Rabies Prevention?

Many people consider cat injuries less dangerous compared with dog bites. However, cats can also transmit rabies virus through bites, scratches, or saliva contact with damaged skin and mucous membranes. Especially in situations involving stray cats or unknown vaccination status animals, professional medical evaluation and prevention measures are highly important.

According to exposure classification principles, different cat-related injuries require different prevention approaches:

1. Scratch exposure: Cat scratches, even without visible bleeding, may require attention because damaged skin can become a potential entry route for viruses.

2. Bite exposure: Cat bites with skin penetration and bleeding are considered higher-risk exposure situations and require immediate medical assessment.

3. Saliva contact: Contact between cat saliva and wounds or mucous membranes may create exposure risks that require professional prevention procedures.

Protection Advantages

AIM Honor’s rabies vaccine solutions are developed around three key requirements: effective immune response, safety during use, and compliance with standardized production requirements. These advantages help healthcare providers select suitable rabies prevention products for different exposure scenarios.

High Immune Response Capability

Both vaccine solutions use rabies virus strains with strong immunogenicity. The conventional vaccine uses the indigenous aG strain, while the serum-free vaccine adopts the PV-2061 strain.

Based on the provided product information, the seroconversion rate reaches 100% at 14 days after vaccination, and the neutralizing antibody level exceeds the WHO protective threshold of 0.5IU/ml, helping establish an effective immune barrier after cat-related exposure.

Safety-Focused Manufacturing

Safety is an important consideration during rabies vaccination. AIM Honor applies strict production control procedures to reduce unnecessary risks during vaccine manufacturing.

1. Conventional Vero Cell Vaccine: No preservatives are added, and residual bovine serum albumin is controlled at ≤10ng per dose according to the provided product information.

2. Serum-Free Vero Cell Vaccine: The manufacturing process adopts serum-free culture technology, reducing risks associated with bovine serum during production.

3. User Consideration: The main reported adverse reaction is mild local pain, which generally resolves within 1-3 days, supporting use among different age groups under professional medical guidance.

Technical Specifications

AIM Honor provides different rabies vaccine solutions according to different clinical and prevention requirements. The following technical information is based on the product materials provided and focuses on the key specifications of the vaccine products for professional reference.

Vaccination Schedule

After cat bite or scratch exposure, vaccination should follow professional medical evaluation and standardized rabies prevention procedures. Human Rabies Vaccine For Cat Related Injuries Prevention is applied according to recommended immunization schedules to support effective immune protection after exposure.

For Category II and Category III exposure caused by cats, the commonly used five-dose intramuscular injection schedule includes vaccination on days 0, 3, 7, 14, and 28. The injection site is usually the deltoid muscle of the upper arm, while the anterolateral thigh may be selected for infants according to professional medical guidance.

For Category III exposure, Rabies Immunoglobulin may also be required according to exposure evaluation. The recommended infiltration injection dosage provided in the product information is 20IU/kg. Healthcare professionals should determine the appropriate prevention plan according to individual exposure conditions.

Standard Immunization Process

A complete vaccination process requires attention to every step from wound management to follow-up vaccination. Proper implementation helps improve prevention effectiveness after possible rabies exposure.

1. Immediate wound cleaning: Wash the wound with soap water or clean water for more than 15 minutes, then disinfect with iodophor or alcohol according to professional recommendations.

2. Professional medical assessment: Healthcare providers evaluate exposure type, wound condition, and animal situation before selecting the appropriate prevention method.

3. Complete vaccination schedule: Complete all required vaccine doses according to the recommended schedule without interruption to support antibody formation.

Quality Assurance

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on vaccine research, development, manufacturing, and quality management. The company provides rabies prevention products through standardized production systems and professional pharmaceutical management practices.

The conventional rabies vaccine has obtained National Drug Approval Number S20073014. According to the provided company information, the product has maintained a 100% batch release qualification rate for 17 years.

The serum-free Vero cell rabies vaccine has completed Phase III clinical trials, and the marketing authorization application has been accepted by the Center for Drug Evaluation (CDE). The production process complies with WHO Specifications for the Use of Biological Products Raw Materials.

Professional Manufacturing Support

AIM Honor continues to improve vaccine production capability through technology development and manufacturing management. The company provides professional cooperation support for medical institutions, distributors, and organizations requiring stable rabies prevention solutions.

1. Manufacturing capability: AIM Honor has established professional vaccine production systems to support stable product supply.

2. Quality management: Product manufacturing follows pharmaceutical quality requirements with strict process control.

3. Supply experience: The products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China.

Company Strength

Choosing a reliable vaccine partner requires not only product performance but also manufacturing experience, quality systems, and supply capability. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on providing professional rabies prevention solutions for domestic and international customers.

As a professional supplier of Human Rabies Vaccine For Cat Related Injuries Prevention, AIM Honor supports different cooperation models including medical institution supply and international procurement requirements. The company continues to contribute to rabies prevention and control through vaccine innovation and professional services.

Application Scenarios

Cat-related injuries may occur in different environments, including household pet interactions, animal rescue activities, veterinary work, and outdoor situations involving stray cats. Human Rabies Vaccine For Cat Related Injuries Prevention provides a professional prevention option for individuals and healthcare organizations dealing with potential rabies exposure.

Different users may have different prevention requirements. AIM Honor’s rabies vaccine solutions are designed to support professional medical use in various situations where rabies exposure evaluation and vaccination are required.

1. Medical institutions: Hospitals, clinics, and CDC organizations can use professional rabies vaccine solutions to support post-exposure prevention services for patients with cat scratches or bites.

2. Animal-related professionals: Veterinarians, animal care workers, and people frequently contacting animals may require professional rabies prevention awareness and vaccination support.

3. Emergency exposure situations: Individuals exposed to stray cats or unknown-status cats can seek medical evaluation and follow recommended rabies prevention procedures.

Why Choose AIM Honor

A reliable rabies vaccine supplier requires comprehensive capability, including research strength, manufacturing experience, product quality management, and stable supply ability. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. combines pharmaceutical expertise with professional vaccine production experience to support global rabies prevention needs.

Research And Development Capability

AIM Honor focuses on biological product development and continuously improves vaccine technology. The company provides both conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine solutions to meet different market and medical requirements.

Through technology improvement and process optimization, AIM Honor supports the development of safer and more efficient rabies prevention products for healthcare applications.

Global Cooperation Support

With long-term supply experience in more than 2000 CDC institutions and medical institutions across China, AIM Honor has accumulated practical experience in vaccine supply and cooperation.

The company welcomes cooperation with international distributors, healthcare organizations, and professional partners requiring stable rabies vaccine solutions. Professional communication, product information support, and supply coordination are provided according to customer requirements.

Product Comparison

AIM Honor provides two types of Vero cell rabies vaccine solutions. Customers can select suitable products according to application requirements, medical recommendations, and procurement considerations.

FAQ

Q: What should I do after being bitten or scratched by a cat?

A: After a cat bite or scratch, clean the wound immediately with soap water or clean water for more than 15 minutes and disinfect the area according to professional recommendations. Medical evaluation should be obtained as soon as possible to determine whether rabies vaccination and other prevention measures are required.

Q: Is rabies vaccination necessary after every cat scratch?

A: The need for vaccination depends on exposure classification, wound condition, and animal situation. Cat scratches may still create exposure risks, especially when the skin is damaged or the animal health status is unknown. Professional medical assessment is recommended.

Q: How many doses are included in the rabies vaccination schedule?

A: According to the provided product information, the commonly used intramuscular vaccination schedule for Category II and Category III exposure includes five doses on days 0, 3, 7, 14, and 28. Healthcare professionals should determine the final vaccination plan according to individual conditions.

Q: What types of rabies vaccine products does AIM Honor provide?

A: AIM Honor provides conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine solutions. Both products are developed for rabies prevention needs and use Vero cell culture technology.

Q: What makes AIM Honor a reliable rabies vaccine supplier?

A: AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. has professional vaccine manufacturing capability and long-term supply experience. According to the provided company information, its products have been supplied to more than 2000 CDC institutions and medical institutions across China, supporting professional rabies prevention services.

Conclusion

Rabies prevention after cat bites and scratches requires timely action, professional evaluation, and standardized vaccination procedures. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides reliable vaccine solutions based on Vero cell technology, manufacturing experience, and quality management systems.

For healthcare organizations, distributors, and professional buyers seeking Human Rabies Vaccine For Cat Related Injuries Prevention, AIM Honor offers stable supply support and professional cooperation services. The company continues to contribute to global rabies prevention and control through trusted vaccine products and pharmaceutical expertise.